Literature DB >> 22188961

[Pancreatic cancer: the surgeon's point of view].

B Franssen1, C Chan.   

Abstract

INTRODUCTION: Pancreatic adenocarcinoma (PA) is not only one of the most common gastrointestinal tumors, but also the most lethal.
OBJECTIVE: Give a comprehensive and up-to-date panorama on pancreatic cancer with a surgical focus.
METHODS: A critical search was performed in Medline focusing on recent relevant publications, renowned authors, high impact publications and a preference for surgical literature in English.
RESULTS: In this article we review PA epidemiology, some aspects of molecular biology, clinical presentation, work-up, staging and current treatment options.
CONCLUSIONS: Patients affected must be studied appropriately and referred to specialized centers for surgical treatment, when indicated, in order to offer them the best chance for cure. Breakthroughs in management will probably include prevention, early diagnosis and molecular therapy.

Entities:  

Mesh:

Year:  2011        PMID: 22188961

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


  2 in total

1.  Cytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: A case report and review of the literature.

Authors:  Wei Li; Lin Ping Xu; Ling DI Zhao; Li Wang; Yong Zhang; Quan Li Gao; Ling Mai
Journal:  Oncol Lett       Date:  2013-02-19       Impact factor: 2.967

2.  Metabolomic biomarkers of pancreatic cancer: a meta-analysis study.

Authors:  Khyati Y Mehta; Hung-Jen Wu; Smrithi S Menon; Yassi Fallah; Xiaogang Zhong; Nasser Rizk; Keith Unger; Mark Mapstone; Massimo S Fiandaca; Howard J Federoff; Amrita K Cheema
Journal:  Oncotarget       Date:  2017-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.